Mr Andrew Weidhaas > Goodwin > New York, United States > Lawyer Profile
Goodwin Offices
THE NEW YORK TIMES BUILDING
620 EIGHTH AVENUE
NEW YORK NY 10018
NEW YORK
United States
- Firm Profile
- Go to...
Mr Andrew Weidhaas
Position
Partner
Career
AJ Weidhaas is a partner in and former Co-Chair of Goodwin’s Private Equity group, and previously served as chair of the firm’s Santa Monica office. AJ serves on the firm’s Allocations Committee and has previously served on its Executive Committee and as chair of the New York Business Law department. He specializes in private equity and M&A transactions, including growth equity investments, leveraged buyouts and leveraged recapitalizations, going private transactions, SPACs and deSPACS. AJ’s experience ranges from the representation of growth companies in financings and buyouts in the middle market through later stage growth equity investments and LBOs and the representation of strategics in private and public M&A. His industry expertise includes technology, healthcare, consumer products, defense, real estate and financial services.
AJ’s clients include private equity sponsors Behrman Capital, Bregal Sagemount, Great Hill Partners, company clients KIND Snacks, Hyperice, Vertellus Manufacturing and MiraDx, and a number of Fortune 50 financial institutions in M&A and financing transactions.
Education
JD, 1993 Stanford Law School (with distinction) / BA, 1990 Yale University (magna cum laude, with distinction)
Lawyer Rankings
United States > M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
Goodwin has established its reputation for providing high-quality advice to mid-market PE firms and blue-chip clients, covering the full spectrum of areas such as growth equity, acquisitions, dividend recaps, leveraged buyouts and exits. While being particularly strong in the technology sector, the firm’s clients benefit from a broad industry focus which includes life sciences, real estate, and financial industries. In Boston, PE co-chair John LeClaire has extensive experience of leveraged recapitalizations, buyouts and minority investments. Santa Monica-based co-chair Andrew Weidhaas is a trusted advisor to major clients such as Behrman Capital, Great Hill, and Primus, while in Boston, co-chair Michael Kendall has specialist expertise of the software, telecoms and healthcare industries. Stuart Rosenthal is a key member of the team in New York, who assists both early stage growth companies and later stage private companies on a diverse range of transactions.
United States > M&A/corporate and commercial > M&A: middle-market ($500m-999m)
Able to call upon a network of intellectual property, real estate and tax experts, Goodwin is best known for its strong track record in complex M&A involving life sciences, tech, and private equity players. The department is well positioned to handle public and private M&A, leveraged buyouts, and spin-offs, and is also skilled in shareholder activism defense and proxy contests. Based in Boston, Stuart Cable spearheads the global M&A practice. Cable is counsel of choice for a number of leading tech and life sciences clients, who retain him on a recurrent basis in transactional and corporate governance matters. On the West Coast, Alessandra Simons is a prominent M&A figure in San Francisco, while Andrew Weidhaas in Los Angeles focuses on private equity deals and emerging companies.
Lawyer Rankings
- M&A: middle-market ($500m-999m) United States > M&A/corporate and commercial
- Private equity buyouts: large deals ($500m+) United States > M&A/corporate and commercial
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)